Primary ductal adenocarcinoma of the lacrimal sac: the first reported case.

This report is the first to demonstrate that mTOR pathway proteins, which are central proteins involved in carcinogenesis, are activated in ductal adenocarcinoma. Therefore, mTOR inhibitor may be a potential candidate for treatment of this highly aggressive carcinoma. PMID: 24040460 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24040460?dopt=Abstract

Source: International Journal of Clinical and Experimental Pathology - September 17, 2013 Category: Pathology Authors: Ishida M, Iwai M, Yoshida K, Kagotani A, Kohzaki H, Arikata M, Shimizu T, Okabe H Tags: Int J Clin Exp Pathol Source Type: research